Scientific and Clinical Advisory Committee

The Scientific and Clinical Advisory Committee Chaired by Professor Matthews comprises Dr Jasper (CSO), Dr Fraser (CEO & MD) and Dr Brookes (Company Chairman), with other invited guests providing additional expertise as needed.

This Committee provides the Board with advice on the scientific and clinical aspects of product development by RHS. This Committee is focussed on ensuring that the competitive attributes of EmbryoCellect® and DOPlify™ are clinically appealing; the Committee also identifies opportunities for further product enhancement and improvement. 

Left to right: Dr David Brookes (Company Chairman), Dr Michelle Fraser (CEO & MD), Professor Colin Matthews AO (Chair) and Dr Melinda Jasper (CSO).